Nature Communications

Tirzepatide versus GLP-1 receptor agonists and stroke in patients with atrial fibrillation and type 2 diabetes

By Chih-Lang Lin, Kuan-Chou Lin, Jung-Min Yu, Szu-Yuan Wu

Fig. 1. STROBE-compliant patient flow diagram. — Fig. 1. STROBE-compliant patient flow diagram.STROBE-compliant patient flow diagram.Lin et al.

Cohort study in peopleInterventions

Declared no competing interests

The paper

Chih-Lang Lin, Kuan-Chou Lin, Jung-Min Yu, Szu-Yuan Wu

Chang Gung University; Asia University

Nature Communications, 22 Aug 2026

doi.org/10.1038/s41467-026-77047-5 PubMed 42778559

Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Neurology Genetics4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
Cardiology and Therapy4 Oct 2026
Low-carb telemedicine links to fewer cardiovascular events
Journal of Cardiovascular Electrophysiology7 Oct 2026
Heart failure rose in US deaths linked to atrial fibrillation